Outreach mailer for Chronic Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Geisinger, Danville, PA
Chronic Disease+3 More
Outreach mailer - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study is evaluating whether a postcard or letter can encourage patients to return to the clinic.

See full description

Eligible Conditions

  • Chronic Disease
  • Prevention
  • Health Promotion
  • Behavior, Risk Reduction

Treatment Effectiveness

Study Objectives

This trial is evaluating whether Outreach mailer will improve 1 primary outcome, 3 secondary outcomes, and 2 other outcomes in patients with Chronic Disease. Measurement will happen over the course of 14 days.

14 days
Patients - Appointment scheduling - Comparing mailers
180 days
Patients - Attendance at scheduled appointments within 180 days of mailer
Patients, Members & Medicaid - Attendance at any appointment
Patients, Members & Medicaid - Timing of appointment
30 days
Patients - Appointment scheduling
Patients - Calls to scheduling line

Trial Safety

Trial Design

4 Treatment Groups

No-contact Control
1 of 4
Physician Letter
1 of 4
Outreach Postcard
1 of 4
Humorous Postcard
1 of 4
Active Control
Experimental Treatment

This trial requires 18400 total participants across 4 different treatment groups

This trial involves 4 different treatments. Outreach Mailer is the primary treatment being studied. Participants will be divided into 3 treatment groups. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Physician LetterThis group receives a personalized letter signed by a physician with information about why visits are important, and what to expect at the appointment.
Outreach Postcard
Behavioral
This group receives a postcard with a stock image on the front and a message encouraging regular visits to manage health on the back.
Humorous PostcardThis group receives a postcard with with a cartoon image and a visit-related joke on the front and a humorous message on the back, with additional information about why visits are important, and what to expect at the appointment.
No-contact ControlThis group will not receive a study mailer during the trial.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Humor/Salience
2020
N/A
~41480
Information
2008
Completed Phase 2
~22010

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 180 days
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 180 days for reporting.

Who is running the study

Principal Investigator
A. G.
Amir Goren, Program Director, Behavioral Insights Team
Geisinger Clinic

Closest Location

Geisinger - Danville, PA

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 3 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
If you are a Geisinger patient, a Geisinger Health Plan member or a Medicaid patient, you can get your prescription refilled at any of our pharmacies. show original
Chronic illness
No appointment for more than a year. show original

Patient Q&A Section

How does outreach mailer work?

"Results from a recent paper suggest that mailers will improve outreach and provide the most benefit when mailers are recruited within their primary care providers' practice." - Anonymous Online Contributor

Unverified Answer

What are the signs of chronic disease?

"Findings from a recent study shows that many patients who are in remission on antiepilepsy drugs have a disease course similar to the natural course of disease. The most common pattern of the disease course was one of the coexistence of acute phase and chronic disease with long periods between attacks, followed by the development of acute phase disease and return to chronic stage. Patients at risk for developing chronic diseases require full medical and psychosocial management so as to reduce the impact of the disease on the life of the patient and reduce the risk of disease progression." - Anonymous Online Contributor

Unverified Answer

How many people get chronic disease a year in the United States?

"In the US, 1.5 million cases of diabetes, chronic heart disease, chronic kidney disease, and chronic liver disease are estimated to occur each year. There will, therefore, be significant increases in health service expenditures in the United States, which will negatively affect the economy as a whole." - Anonymous Online Contributor

Unverified Answer

Can chronic disease be cured?

"The question of what cures chronic disease remains unanswered. The cure is only 'cure' when the medical intervention achieves the therapeutic objectives that the patient has in mind. However, it may be possible to define chronicity as a'steady state', beyond which treatment is futile, and it seems that there are a few diseases that may be able to enter a steady state, and remain'stable' - at least for a time. This may be demonstrated by a study showing that some autoimmune diseases may enter a chronic state, beyond which no further treatment - for the time being - achieves anything other than a very slow and steady decline." - Anonymous Online Contributor

Unverified Answer

What are common treatments for chronic disease?

"Chronic diseases are disabling in many respects, and the treatments they require are often difficult to access and prohibitive in cost. In developing countries people often do not have access to modern medical technologies despite being fully informed of potential cures, and the best treatments still require medical supervision. There is not a single 'chronic disease' that can be seen as'saber-tooth' as the best way to think about a treatment plan for a patient requires the health worker to appreciate that the type of treatment and management has to take into account many factors across a wide range of diseases. Most of the treatments discussed are expensive: many in developing countries are prohibitively costly depending on the degree of coverage, and patients are frequently unable to pay." - Anonymous Online Contributor

Unverified Answer

What causes chronic disease?

"There is a tendency in modern American culture to blame external physical factors for diseases such as heart disease, lung disease, diabetes, and cancer. Therefore, chronic disease prevention should begin with understanding how to control external factors and should be the first line of work. This article presents convincing rationale for the importance of preventing disease in young people by lifestyle interventions, which are both affordable and can also be effective in preventing disease in older adults as well." - Anonymous Online Contributor

Unverified Answer

What is chronic disease?

"Chronic diseases are a significant part of the global burden of disease. There are an estimated 1.4 billion people currently living with chronic diseases in the world, and they will become more common as the burden of disease escalates. If future preventive care efforts are to be effective, it will be essential to target the chronic lifestyle risk factors that are known to drive chronic disease in high-income settings, or to improve the health of countries and regions where chronic diseases are increasing more widely. Further, it will be important to develop and test methods and messages relating to chronic disease prevention and reduction targeting high-risk populations and high-risk countries and regions." - Anonymous Online Contributor

Unverified Answer

What are the latest developments in outreach mailer for therapeutic use?

"The use of therapeutic mailing lists has been growing in the past decade in order to reach out to patients who don't have access to clinics at all. This type of mailing list is very helpful for many. A recent study from the United Nations Millennium Development Goals reports has also proven that this type of mailing list is very profitable for one to use as a means of helping. It not only enhances communication between people but also saves on time. A study on one mailing list found that the time saved on communication between people is around 3 hours. A number of countries in the world still use this type of mailing list because it boosts the well being of the people and it has a great impact in promoting healthier lifestyles amongst the group." - Anonymous Online Contributor

Unverified Answer

Who should consider clinical trials for chronic disease?

"Although the use of clinical trials for chronic diseases has expanded over time, the decision to participate in an ongoing clinical trial can be difficult. Patient characteristics, burden of disease, and treatment options all influence whether a clinical trial is offered." - Anonymous Online Contributor

Unverified Answer

What is the primary cause of chronic disease?

"The study shows that there is no difference in the perceptions of primary causes of chronic disease experienced by patients enrolled in clinical trials and those who are not part of the clinical trial. Furthermore, the study shows that some of the patients who are part of clinical trials were able to correctly identify the primary cause of their chronic disease, while many patients in general were not able to identify the primary cause of their illness. Results from a recent paper highlights key factors in chronic patient's perception of what are, the primary causes of chronic illness that make the difference on the long-term illness outcome." - Anonymous Online Contributor

Unverified Answer

What does outreach mailer usually treat?

"The most frequently cited reason as to why respondents were prescribed the most common medications was for chronic conditions. Nearly one third of respondents reported having been prescribed high potency [Dipclonine, also known as a heart medication or heart relaxer], high-strength [Dihydrozoline HCL 50, also known as a muscle relaxer], and/or high-frequency (2 or more times a day)/high potency [Dipethadrol HCL 25, also known as a [decongestive], bronchodilator, or short-term bronchodilator] [when prescribed] or [aspartame or sweetener (for a nonalcoholic beverage)] for more than one month." - Anonymous Online Contributor

Unverified Answer

Have there been other clinical trials involving outreach mailer?

"Outreach mailers have been researched in many fields including diabetes, arthritis, Alzheimer's disease, multiple sclerosis, etc. However, clinical trials that use them are relatively very few. We hope that our article will help some researchers and pharmaceutical companies in their research of these outreach mailer." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
See if you qualify for this trial
Get access to this novel treatment for Chronic Disease by sharing your contact details with the study coordinator.